Dialyzable factor in human serum of platelet origin stimulates endothelial cell replication and growth by Clemmons, D. R. et al.
Proc. NatL Acad. Sci. USA
Vol. 80, pp. 1641-1645, March 1983
Cell Biology
Dialyzable factor in human serum of platelet origin stimulates
endothelial cell replication and growth
(atherosclerosis/mitogen/growth factor/repair)
DAVID R. CLEMMONS, WILLIAM L. ISLEY, AND M. TODD BROWN
Department of Medicine, Center for Thrombosis and Hemostasis, University of North Carolina, Chapel Hill, North Carolina 27514
Communicated by K. M. Brinkhous, December 13, 1982
ABSTRACT Porcine aortic endothelial cells were isolated and
maintained in Dulbecco's modified Eagle's medium (DME me-
dium)/10% citrate-treated human plasma. They were stimulated
by DME medium/10% human serum to grow from a density of
10,100 ± 500 per well to a final density of 83,000 ± 1,800 per well
over a 9-day period. On the other hand these cells grew poorly
(11% increase) in DME medium/10% human platelet-poor plasma
prepared without chelating agents and containing platelet factor
4 at 18 ng/ml by radioimmunoassay. Dialysis of the human serum
(Mr cutoff, 3,500) eliminated all the stimulatory activity. The ac-
tivity recovered from the dialysate stimulated growth when added
to endothelial cultures in conjunction with either dialyzed serum
or platelet-poor plasma alone. The dialyzable factor could be ob-
tained directly from platelets; both acetic acid extracts and boiled
NaCI extracts stimulated porcine aortic endothelial cell replica-
tion. Gel filtration chromatography on Sephadex G-15 showed that
the endothelial growth factor had a molecular weight of 700. Par-
tially purified material induced a concentration-dependent stim-
ulation of porcine aortic endothelial cell replication in the pres-
ence of DME medium alone; however, simultaneous incubation
with platelet-poor plasma resulted in a much greater response. Fi-
broblast growth factor isolated from bovine brain was found to be
mitogenic only in the presence of nondialyzed serum or of the di-
alyzable factor together with plasma. In the absence of this serum
factor, fibroblast growth factor had no effect. We conclude that
human serum contains a potent endothelial cell mitogen of platelet
origin. Human plasma that is devoid of platelet content does not
stimulate endothelial cell growth. This growth factor may be an
important stimulant of the endothelial cell response to vascular
wall injury.
Vascular endothelial cells form a selective barrier to the trans-
port of nutrients and macromolecules to subendothelial tissues
(1). Disruption of this single layer of endothelial cells results in
loss of the barrier function and exposure of both the damaged
endothelium and the subendothelium to plasma molecules (2).
Platelets immediately adhere to subendothelial substances such
as collagen, and this may result in subendothelial exposure to
released platelet contents (3). Platelets have been shown to re-
lease platelet-derived growth factor, a potent mitogen for smooth
muscle cells (4), and fibroblasts (5). Because damaged endothe-
lial cells are directly exposed to platelet contents, one would
expect that growth factors released after platelet adhesion might
have potent stimulatory effects for this cell type. Repair of en-
dothelium is not believed to be dependent on platelet-derived
growth factors, however, since dialyzed serum supplements do
not have greater mitogenic activity than citrated plasma for cul-
tured vascular endothelial cells (6, 7). However, like serum, ci-
trated plasma contains greater concentrations of platelet factor
4 (PF4) (8) than EDTA-treated plasma, indicating that platelet
release of a granules has occurred and that intracellular factors
have been released. The presence of one or more of these fac-
tors might obscure presumed differences between citrated plasma
and serum. Furthermore, dialysis of citrated plasma or serum
reduces their mitogenic activity for endothelial cells when com-
pared with nondialyzed serum (9). It is possible, therefore, that
results obtained by comparing dialyzed citrated plasma and serum
are not strictly applicable as an in vivo model of vascular injury.
We, therefore, undertook the present study to make a direct
comparison between nondialyzed serum and plasma that con-
tained minimal or no platelet content and to determine whether
serum contains an endothelial cell mitogen that can be removed
by dialysis. Since platelet adhesion to vessel walls may be an
important determinant of the response to vascular injury, we
also investigated whether platelets were the source of this en-
dothelial mitogen.
MATERIALS AND METHODS
Preparation of Plasma and Serum. Citrated human plasma
(16 mM Na citrate/7 mM citric acid) was purchased from the
American Red Cross. One liter of plasmawas centrifuged at 1,800
x g for 15 min, and the supernatant was centrifuged at 22,000
x g for 30 min to remove residual platelet contents. The su-
pernatant was recalcified by adding 20 ml of 1.0 M CaCl2 and
incubating the solution at 370C for 2 hr. After clot formation, the
solution was centrifuged at 22,000 x g for 30 min and the su-
pernatant was dialyzed against 13 liters of Ringer's bicarbonate
buffer (pH 7.4) for 24 hr at 40C. Extensively dialyzed citrated
plasma was prepared by heating this material to 370C for 24 hr
and dialyzing against Ringer's bicarbonate buffer (pH 7.4) for 5
days at 40C. Citrated platelet-rich plasma was obtained from
outdated platelet packs containing 10 units of platelets and 40
ml of residual plasma. The plasma was separated from the plate-
lets by centrifugation and prepared by a method identical to that
used to prepare citrated plasma. EDTA- and oxalate-treated
plasma specimens were prepared by placing freshly drawn blood
obtained from normal adult donors in glass tubes containing 150
mM EDTA or 10 mM Na oxalate and centrifuging at 1,800 X
g for 15 min. The plasma was recalcified by adding 1.0 M CaCl2
to a final Ca2+ concentration of 20 mM. It was then centrifuged
at 1,800 x g for 15 min and the supernatant was subsequently
heated to 560C for 30 min. Heparin-treated plasma was obtained
by placing freshly drawn blood in a 10-ml prechilled (40C) glass
tube and then adding 143 units of heparin and centrifuging at
1,800 X g for 15 min. Human serum was prepared by placing
freshly drawn blood in glass tubes, allowing it to clot, and cen-
trifuging it for 15 min at 1,800 x g. The supernatant was stored
at -200C until use. Dialyzed serum was prepared by using
Abbreviations: PF4, platelet factor 4; DME medium, Dulbecco's mod-
ified Eagle's medium; FGF, fibroblast growth factor; PDECM, plate-
let-derived endothelial cell mitogen.
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Spectropor 3 membranes (Spectrum Medical Industries) (Mr
cutoff, 3,500) and dialyzing for 24 hr at 40C with three exchanges
of Ringer's bicarbonate buffer (pH 7.4) [ratio, 1:100 (vol/vol)].
Human platelet-poor plasma was obtained by placing freshly
drawn blood in prechilled (40C) plastic tubes, immediately cen-
trifuging at 1,800 x g for 15 min, and then centrifuging the su-
pernatant at 22,000 X g for 30 min. The fibrinogen was pre-
cipitated with broken glass and the solution was clarified by
centrifugation. The supernatant was heat inactivated at 560C for
30 min. The PF4 contents of the plasma preparations were de-
termined by radioimmunoassay (10) (carried out by G. White).
The limit of detectability in this assay is < 1 ng/ml and the PF4
concentration in EDTA plasma is 0-15 ng/ml.
Purification of Endothelial Cell Growth Factor. Platelet-
rich plasma was obtained from outdated (10-unit) platelet packs
(American Red Cross), each containing 40 ml of residual plasma.
The platelet/plasma mixture (400 ml) derived from 100 units of
platelets was incubated at 370C for 4 hr and then filtered through
a YM-5 filter (Amicon). Fifty milliliters of the filtrate was acidi-
fied with 1 M acetic acid (1:1) and lyophilized to dryness. The
lyophilized material was reconstituted in 2.0 ml of 0.5 M acetic
acid; 1.0 ml was applied to a Sephadex G-15 (Sigma) column (90
X 1.6 cm) and eluted with 0.5 M acetic acid (pH 2.9) at a flow
rate of 1.0 ml/min. The column was calibrated usingbovine serum
albumin, thyrotropin-releasing hormone (TRH), and Na125I. The
2.0-ml fractions that were collected were also lyophilized to dry-
ness. These fractions were reconstituted in 2.0 ml of Dulbecco's
modified Eagle's (DME) medium and their activity was deter-
mined by their capacity to stimulate [3H]thymidine incorpo-
ration into quiescent porcine endothelial cells.
Preparation of Platelet Extracts for Biological Studies. NaCl
platelet extracts were prepared by centrifuging 6 units of out-
dated platelet plasma mixture at 10,000 x g for 30 min to re-
move residual plasma. The platelet pellet was suspended in 2
vol of 0.01 M Na2HPO4/0.9 M NaCl, pH 7.4, and freeze-thawed
three times. The suspension was centrifuged at 5,000 x g for
30 min and the supernatant was tested for mitogenic activity.
Boiled extracts were prepared by heating the NaCl extract to
100TC for 15 min, allowing the extract to cool to 240C, and cen-
trifuging it at 5,000 x g for 10 min. Acetic acid extracts of plate-
lets were obtained by suspending the pellet from 6 units of out-
dated platelets in 2 vol of 0.5 M acetic acid, pH 2.9, and stirring
for 14 hr at 4TC. The suspension was centrifuged at 5,000 X g
for 30 min and the supernatant was neutralized to pH 7.4 with
10 M NaOH.
Preparation of Fibroblast Growth Factor (FGF). FGF was
purified from bovine brain extracts by a published method (11).
The purification procedure was monitored by testing the capac-
ity of column fractions to stimulate DNA synthesis in BALB/c
3T3 cells (12). At 55 ng/ml, the partially purified material stim-
ulated [3H]thymidine incorporation equal to 10%o bovine serum.
Isolation of Endothelial Cells. Porcine aortic endothelial cells
were isolated as described (13). Aortas from young piglets were
incubated for 30 min at 370C in DME medium (Flow Labora-
tories)/0. 1% type II collagenase (Worthington, lot 42C074; 126
units/mg). The endothelial cells that detached were plated in
two 10-cm dishes (Falcon) in DME medium/20% bovine serum
(Colorado Serum, Denver, CO). After attachment (6-8 hr), the
medium was removed and replaced with DME medium/10%
citrated human plasma. The cells were removed from the plates
with 0.5% trypsin/0.2% EDTA (GIBCO) and subcultured every
10-15 days at a split ratio of 1:3. Cells processed in this manner
formed a homogenous monolayer, had double nucleoli, had no
myofilamnents by electron microscopy, and stained for factor VIII-
related antigen (14). There was no evidence of transformation
or loss of the endothelial monolayer (15, 16) under these con-
ditions for periods of up to 6 wk.
Assessment of Growth of Cultured Endothelial Cells. For
growth experiments, porcine endothelial cells were subcul-
tured at a plating density of 10,000 cells per well in 1.5-cm 24-
well plates (Falcon) using DME medium/10% citrated plasma.
The cells were incubated for 4 hr to allow attachment, and then
the medium was removed and the test media were added. After
a 72-hr incubation, the media were aspirated from duplicate wells
for determination of cell number. The cells were removed by
incubating for 10 min in 0.5% trypsin/0.2% EDTA. The cell
suspension was withdrawn and added to 9.5 ml of 0.15 M NaCl
and cell number was determined in a particle counter (Coulter
model ZBI). The remaining wells received fresh test media and
this procedure was repeated every 3 days.
[3H]Thymidine Incorporation. To assess DNA synthesis,
porcine endothelial cells were plated in microtest wells (Falcon)
at 5,000 cells per well in DME medium/3% platelet-poor plasma
(total vol, 200 1.l). After 3 days, test materials were added di-
rectly with 0.5 pxCi of [methyl-3H]thymidine (6 Ci/mmol; 1 Ci
= 37 GBq) (Schwartz-Mann). Test mixtures were incubated for
36 hr, and wells were washed twice with Ringer's bicarbonate
(pH 7.4) at 40C and twice with 5% trichloroacetic acid. The DNA
was extracted with two 0.2-ml portions of 0.1 M NaOH/1%
NaDodSO4, and the radioactivity was determined by liquid
scintillation counting.
RESULTS
Porcine Endothelial Cell Growth Requires a Dialyzable
Serum Factor. Porcine aortic endothelial cells that had been
maintained in medium containing 10% citrated human plasma
for three passages were plated at 10,000 cells per well and their
growth rate was determined. Cultures exposed to 10% human
serum grew from a density of 10,100 cells per well to a density
of 83,000 cells per well over the 9-day test period. On the other
hand, cells exposed to 10%o platelet-poor plasma remained nearly
stationary over this interval (11% increase) (Fig. 1). Dialysis of
serum removed the growth-stimulating activity (Fig. 2). The
serum dialysate was concentrated 1,000-fold by evaporation to
the original serum volume (1.0 ml), and addition of 0.05 ml of
this concentrate to 0.5 ml of DME medium/10% dialyzed
platelet-poor plasma gave medium that stimulated endothelial
cell growth to a final cell density comparable with that of normal
serum (Fig. 2). These results are consistent with the hypothesis
that the mitogenic factor is removed by dialysis rather than in-
activated.
The Dialyzable Factor Is of Platelet Origin. Because serum
supported growth much more effectively than plasma, it ap-
peared that the dialyzable mitogen might be derived from plate-
lets. Therefore, outdated human platelet concentrates were ex-
tracted under a variety of conditions. Extracts prepared by using
0.5 M acetic acid stimulated [3H]thymidine incorporation 122%
in the presence of 3% platelet-poor plasma (Table 1). An extract
prepared with 0. 15M NaClwas inhibitory; however, after it was
boiled, there was a 73% increase in DNA synthesis. To distin-
guish between the possibility of inhibitor inactivation by boiling
versus generation of some other stimulant from an inactive form,
nonboiled 0.15 M NaCl extracts were dialyzed or sequentially
dialyzed and boiled. Neither of these maneuvers resulted in a
significant increase in mitogenic activity. A mixing experiment
was carried out in which the nonboiled 0.15 M NaCl extract was
mixed (1:1) with human serum and assayed at a final concen-
tration of 10% serum. This concentration of platelet extract was
found to cause 86% inhibition of serum-stimulated replication.
These results indicated that the endothelial mitogen was not
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FIG. 1. Growth of porcine endothelial cells in human -serum and
platelet-poor plasma. Cells were plated at a density of 10,000 cells per
well in DME medium/10% citrated human plasma, allowing 4 hr for
attachment. Then, the medium was removed and fresh DME medium
containing either 10% serum (0) or 10% platelet-poor plasma (e) (PF4
content, <6 ng/ml) was added. At 72-hr intervals, trypsinized cells in
triplicate wells were counted and the remaining wells received fresh
medium containing serum or plasma. Results are mean ± 1 SD of three
determinations.
generated by heating and that it-was detectable only after de-
struction of inhibitory substances present in the crude platelet
extract.
Because citrated plasma is rich in platelet contents, several
other plasma preparations were compared for growth-stimulat-
ing activity. Recalcified oxalate-, EDTA-, and heparin-treated
plasmas (PF4 values, <18 ng/ml) and platelet-poor plasma were
tested for their PF4 content and their capacity to stimulate en-
dothelial cell replication (Table 2). Each was found to have stim-








FIG. 2. Growth of porcine endothelial cells in dialyzedhuman serum.
Cells were plated as in Fig. 1. After attachment, the cultures were ex-
posed to DME medium containing 10% nondialyzed human serum (r),
10% dialyzed human serum (A), 10% platelet-poor plasma (0), or 10%
concentrated dialysate/10% platelet-poorplasma (0) (final vol, 0.5 ml).
At 72-hr intervals, cells in triplicate wells were counted and the re-
maining wells received fresh DME medium and test serum or plasma.
Table 1. Stimulation of [3H]thymidine incorporation into porcine
endothelial cells by platelet extracts
% increase
Factor over control
Human serum (10%) 255
Platelet-poor plasma (5%) 11
0.5 M acetic acid platelet extract 122
0.15 M NaCl platelet extract -31
Boiled 0.15 M NaCl platelet extract 73
Dialyzed 0.15 M NaCl platelet extract -8
Dialyzed then boiled 0.15M NaCl platelet extract 2
0.15M NaCl platelet extract/10% human serum* 37
Quiescent porcine endothelial cells were plated at 5,000 cells per well.
After cell attachment, each well received 200 A.l of DME medium/3%
platelet-poor plasma. After a 3-day incubation, 0.5 /Ci of [3H]thy-
midine and 5 td of test material were added directly to each well. After
48 hr, [3Hlthymidine incorporation was determined. Control cultures
were exposed to 3% platelet-poor plasma alone.
* The 0.15 M NaCl- extract was added to an equal volume of human
serum and the mixture was incubated at 240C for 30 min and then
added to the endothelial cultures to give a final human serum con-
centration of 10%.
that specific plasma preparation. Citrated platelet-rich plasma
caused the greatest increase in [3Hlthymidine incorporation
(290%). Both incubation at 37TC for 24 hr and exhaustive dialysis
[i.e., a ratio of 1:100 (vol/vol) with six exchanges] were re-
quired to remove the stimulatory factor(s) from citrated plasma.
Properties of the Endothelial Mitogen. A molecular weight
estimate of the platelet-derived endothelial mitogen (PDECM)
was obtained by gel filtration chromatography. One milliliter of
concentrated platelet-rich plasma filtrate was applied to a Seph-
adex G-15 column (90 x -1. 6 cm). The growth-promoting activity
eluted at a distribution coefficient (Kd) of -0.5 corresponding to
a molecular weight of approximately 700 (Fig. 3). It was esti-
mated that approximately 62% of the biological activity was re-
covered in the active fractions and. that the material had been
purified 15-fold over filtered platelet-rich plasma. The active
fractions (Kd, 0.46-0.54) were pooled and further tested for
stimulatory activity. This partially purified extract from plate-
lets stimulated a concentration-dependent increase in porcine
endothelial cell replication when tested in the presence of DME
medium/3% platelet-poor plasma (Fig. 4). In the presence of
DME medium alone (no platelet-poor plasma), PDECM in-
duced much lower increases in thymidine incorporation at each
concentration tested. Therefore, incubation with platelet-poor
plasma enhanced the activity of 'PDECM. PDECM-induced
Table 2. Effect of plasma preparations on endothelial
cell replication
PF4 content,
Plasma type ng/ml % increase over control
Citrated 125 101
Platelet rich (citrated) 850 290
Oxalate treated 8 5
Heparin treated 18 11
EDTA treated 5 -2
Platelet poor 21 16
Extensively dialyzed citrated* 106 12
Plasmas were used at 10%. Control cultures were incubated with 3%
platelet-poor plasma for 3 days and received only [3H]thymidine at the
initiation of the experiment.
* Citrated plasma was incubated at 370C for 24 hr and then dialyzed
against Ringer's bicarbonate [ratio, 1:100 (vol/vol)] for 5 days at 40C.
PF4has a molecular weight of 8,000 and is nondialyzable when using
Spectrapor 3 tubing.
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FIG. 3. Gel filtration chromatography of the endothelial cell growth
factor. One-milliliter of a concentrated filtrate of platelet-rich plasma
was applied to a Sephadex G-15 column that had been equilibrated with
0.5 M acetic acid (pH 2.9). The column (1.6 x 90 cm) was eluted at a
flow rate of 1.0 ml/min, and 2.0 ml fractions were collected. The frac-
tions were lyophilized to dryness and reconstituted in 2.0 ml of DME
medium. The activity in each fraction was determined by adding 5 gl
of the fraction directly to quiescent porcine endothelial cells in DME
medium/3% platelet-poor plasma and measuring [3Hlthymidine in-
corporation after 36 hr. Markers: 1, bovine serum albumin; 2, thyro-
tropin releasing hormone; 3, 1"I. Kd, coefficient of distribution.
stimulation of replication was relatively specific for endothelial
cells. When identical concentrations of PDECM were added to
cultures of BALB/c 3T3 fibroblasts and human fibroblasts and
the results were compared using an identical serum standard,
these cell lines were stimulated only 22% and 7% compared with
endothelial cell stimulation. No activity was obtained when
PDECM was added to smooth muscle cell cultures.
Growth-Promoting Effects of the Endothelial Mitogen. When
stimulation of growth was analyzed, PDECM was found to be
active in the presence of platelet-poor plasma and dialyzed hu-
man serum (Fig. 3). Therefore, partially purified material was
capable of stimulating growth as well as replication. In contrast,
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FIG. 4. Concentration-dependent increase in DNA synthesis by
PDECM. Partially purified PDECM (see Fig. 3) was added at the con-
centrations indicated to quiescent endothelial cell monolayers inDME
medium/3% platelet-poor plasma (c) or DME medium without plate-
let-poor plasma (0). Each well contained 0.5 XCi of [3Hlthymidine. After
a 36-hr incubation, the cells were washedtwice with5% trichloroacetic
acid, and the DNA was extracted with 0.1 M NaOH/1% NaDodSO4.
[3H]Thymidine incorporation was determined by liquid scintillation
counting.
poor plasma or dialyzed human serum, no growth-promoting
activity could be demonstrated (Fig. 5). FGF was active in the
presence of undialyzed human serum but required the simul-
taneous presence of PDECM to be active when incubated with
either platelet-poor plasma or dialyzed human serum. In the
presence of PDECM, FGF induced a further increase in growth
that was greater than that induced by PDECM/platelet-poor
plasma or PDECM/dialyzed human serum.
DISCUSSION
The results of this study show that human serum contains a po-
tent stimulant of porcine endothelial cell replication and growth.
In contrast, human platelet-poor plasma, prepared to contain
minimal concentrations of factors released during platelet ag-
gregation, has virtually no stimulatory effect (Fig. 1). These
findings emphasize that the method of plasma preparation is
crucial to accurate interpretation of results because our data
suggest that the capacity of plasma to stimulate endothelial cell
growth is directly proportional to its PF4 content (Table 2).
Platelet-rich plasma and citrated plasma that contain high con-
centrations of PF4 (>100 ng/ml) are much more potent than
EDTA-treated or oxalate-treated plasma (PF4, <10 ng/ml). The
finding of such a correlation between PF4 content and plasma
mitogenicity suggested that platelets were the source of this
material. Further evidence to support this hypothesis was ob-
tained when it was noted that both platelet extracts and platelet
contents released after degranulation contained a similar mi-
togenic activity (Table 1). Crude extracts also contained inhib-
itors of porcine endothelial cell replication that were removed
by boiling or acid treatment. Platelets, therefore, release a low
molecular weight mitogen that is a potent stimulant of endothe-
lial cell growth.
Dialysis removed the growth-promoting activity from serum
and addition of concentrated dialysate to either dialyzed serum
or platelet-poor plasma restored endothelial cell growth. These








FIG. 5. Effect of FGF on endothelial cell growth. Cells were plated
as in Fig. 1 and then exposed to DME medium containing FGF/5% di-
alyzed human serum/partially purified PDECM (o- ), FGF/5%
platelet-poor plasma/PDECM (A--A), PDECM/platelet-poor plasma
(o--o), PDECM/dialyzed human serum (A A), FGF/human serum
(n-o), FGF/platelet-poor plasma (v--v), platelet-poor plasma
(o-o), or FGF/dialyzed human serum (A-A). After 72 hr of in-
cubation, the cells were detached and counted. As in the previous ex-
periments, the remainder of the wells received fresh DME medium to-
gether with the test reagent(s) for an additional 72 hr and this was
repeated. Concentrations of reagents used: FGF, 50 ng/ml; PDECM,
2.5 Zg/ml; sera and platelet-poor plasma, 5%.
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and this was confirmed by chromatography on Sephadex G-15,
which gave a molecular weight estimate of approximately 700
(Fig. 3). PDECM was also found to be heat and acid stable and,
in the presence of platelet-poor plasma, caused a concentration-
dependent increase in endothelial cell replication (Fig. 4). The
mitogen showed some specificity for endothelial cells since
comparable concentrations were much less effective in stimu-
lating DNA synthesis in both BALB/c 3T3 fibroblasts and hu-
man fibroblasts. PDECM had no effect on replication of cul-
tured porcine aortic smooth muscle cells.
Partially purified PDECM was approximately 40% as effec-
tive in the absence of platelet-poor plasma. Pledger et al (17)
and Ross and Vogel (18) have shown that exposure of fibroblasts
or smooth muscle cells to both platelet-derived growth factor
and platelet-poor plasma results in a synergistic increase in rep-
lication. Like these cell types, endothelial cells require factors
in platelet-poor plasma for the optimal effects of PDECM to
occur (Fig. 5). The availability of PDECM will make it possible
to identify the specific plasma components that are required for
optimal stimulation of endothelial cell growth.
FGF (9), macrophage growth factor (19), and a recently de-
scribed endothelial cell growth factor (20) isolated from bovine
hypothalamus have all been shown to stimulate endothelial cell
growth. Our results show that FGF is inactive in the presence
of platelet-poor plasma or dialyzed serum and that stimulation
of porcine endothelial cells is dependent on the presence of
PDECM. In the presence ofPDECM, however, FGF did stim-
ulate endothelial cell growth, confirming that each factor stim-
ulates growth by a different mechanism. Because each of-these
three factors has been tested in the presence ofserum or citrated
plasma, it is possible that each requires simultaneous exposure
to PDECM.
Citrated plasma that had been dialyzed for 24 hr had mito-
genic activity, but extensive dialysis of citrated plasma after in-
cubation at 370C removed the endothelial cell growth-stimu-
lating activity (Table 2). Several groups have fiLiled to detect an
endothelial cell growth-promoting effect of partially purified
platelet extracts or serum when compared with citrated plasma
(6, 7, 21, 22). In their studies, both platelet extracts and serum
were extensively dialyzed or chromatographed prior to testing;
therefore, low molecular weight substances would have been at
least partially removed. In contrast, inclusion ofwhole platelets
in the incubation medium has been reported to stimulate en-
dothelial cell growth (23, 24). Likewise, nondialyzed bovine serum
had significantly greater stimulatory activity for bovine aortic
endothelial cells than did extensively dialyzed citrated bovine
plasma (9). In summary, these studies support the concept that
serum contains an endothelial cell mitogen that is at least par-
tially removed by dialysis. Our observation that crude NaCl
platelet extracts inhibit endothelial cell replication is consistent
with the findings of Wall et aL (6) and does not exclude the pos-
sibility that platelets are the source of a mitogen. This conclu-
sion is supported by the observation that boiling or acid ex-
traction removes the inhibitory effects of these extracts.
The results of this study may have important implications for
understanding the mechanism of repair of vascular endothe-
lium after injury. Disruption of the integrity of the endothelial
cell layer in vivo results in platelet deposition and release of var-
ious platelet factors. This would result in a high local concen-
tration of platelet mitogens that could initiate replication and
growth after wounding. The presence ofPDECM together with
plasma growth factors would provide an optimal environment
for rapid endothelial cell division. Since endothelial cells with
histologic characteristics similar to "transformed" appearing cells
described in vitro are seen after injury in vivo (20), this factor
might also play a role in initiating the developmentof these cells
after injury.
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